360 related articles for article (PubMed ID: 31496676)
1. Eicosanoids metabolized through LOX distinguish asthma-COPD overlap from COPD by metabolomics study.
Cai C; Bian X; Xue M; Liu X; Hu H; Wang J; Zheng SG; Sun B; Wu JL
Int J Chron Obstruct Pulmon Dis; 2019; 14():1769-1778. PubMed ID: 31496676
[TBL] [Abstract][Full Text] [Related]
2. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic signatures of asthma-COPD overlap (ACO) are different from asthma and COPD.
Ghosh N; Choudhury P; Subramani E; Saha D; Sengupta S; Joshi M; Banerjee R; Roychowdhury S; Bhattacharyya P; Chaudhury K
Metabolomics; 2019 Jun; 15(6):87. PubMed ID: 31165288
[TBL] [Abstract][Full Text] [Related]
4. Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap.
Gao J; Zhou W; Chen B; Lin W; Wu S; Wu F
Int J Chron Obstruct Pulmon Dis; 2017; 12():2703-2710. PubMed ID: 28979112
[TBL] [Abstract][Full Text] [Related]
5. Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.
Romem A; Rokach A; Bohadana A; Babai P; Arish N; Azulai H; Glazer M; Izbicki G
Respiration; 2020; 99(1):35-42. PubMed ID: 31694032
[TBL] [Abstract][Full Text] [Related]
6. Use of clinical characteristics to predict spirometric classification of obstructive lung disease.
Pascoe SJ; Wu W; Collison KA; Nelsen LM; Wurst KE; Lee LA
Int J Chron Obstruct Pulmon Dis; 2018; 13():889-902. PubMed ID: 29559773
[TBL] [Abstract][Full Text] [Related]
7. Decreased serum club cell secretory protein in asthma and chronic obstructive pulmonary disease overlap: a pilot study.
Oh JY; Lee YS; Min KH; Hur GY; Lee SY; Kang KH; Rhee CK; Park SJ; Shim JJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():3411-3417. PubMed ID: 30425470
[TBL] [Abstract][Full Text] [Related]
8. Global metabolome profiling of exhaled breath condensates in male smokers with asthma COPD overlap and prediction of the disease.
Ghosh N; Choudhury P; Joshi M; Bhattacharyya P; Roychowdhury S; Banerjee R; Chaudhury K
Sci Rep; 2021 Aug; 11(1):16664. PubMed ID: 34404870
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and features of asthma-chronic obstructive pulmonary disease overlap in Northern Italy general population.
Guerriero M; Caminati M; Viegi G; Senna G; Pomari C
J Asthma; 2019 Jan; 56(1):27-33. PubMed ID: 29420087
[TBL] [Abstract][Full Text] [Related]
10. Increased urinary l-histidine in patients with asthma-COPD overlap: a pilot study.
Oh JY; Lee YS; Min KH; Hur GY; Lee SY; Kang KH; Rhee CK; Park SJ; Khan A; Na J; Park YH; Shim JJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():1809-1818. PubMed ID: 29892192
[TBL] [Abstract][Full Text] [Related]
11. Sputum Neutrophil Gelatinase-Associated Lipocalin as a Biomarker in Asthma-COPD Overlap.
Babu A; Narayanswamy H; Baburao A
J Assoc Physicians India; 2023 Sep; 71(9):34-38. PubMed ID: 38700299
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap.
Takayama Y; Ohnishi H; Ogasawara F; Oyama K; Kubota T; Yokoyama A
Int J Chron Obstruct Pulmon Dis; 2018; 13():2525-2532. PubMed ID: 30174422
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO).
Ghosh N; Choudhury P; Kaushik SR; Arya R; Nanda R; Bhattacharyya P; Roychowdhury S; Banerjee R; Chaudhury K
Respir Res; 2020 May; 21(1):126. PubMed ID: 32448302
[TBL] [Abstract][Full Text] [Related]
14. Combined Assessment of Serum Periostin and YKL-40 May Identify Asthma-COPD Overlap.
Shirai T; Hirai K; Gon Y; Maruoka S; Mizumura K; Hikichi M; Holweg C; Itoh K; Inoue H; Hashimoto S
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):134-145.e1. PubMed ID: 29981861
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and features of asthma-COPD overlap in the United States 2007-2012.
Mendy A; Forno E; Niyonsenga T; Carnahan R; Gasana J
Clin Respir J; 2018 Aug; 12(8):2369-2377. PubMed ID: 29873189
[TBL] [Abstract][Full Text] [Related]
16. Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort.
Park HY; Lee SY; Kang D; Cho J; Lee H; Lim SY; Yoon HI; Ra SW; Kim KU; Oh YM; Sin DD; Lee SD; Park YB
Respir Res; 2018 Mar; 19(1):36. PubMed ID: 29499758
[TBL] [Abstract][Full Text] [Related]
17. Relationship of Serum Levels of IL-17, IL-18, TNF-
Kubysheva N; Boldina M; Eliseeva T; Soodaeva S; Klimanov I; Khaletskaya A; Bayrasheva V; Solovyev V; Villa-Vargas LA; Ramírez-Salinas MA; Salinas-Rosales M; Ovsyannikov DY; Batyrshin I
Mediators Inflamm; 2020; 2020():4652898. PubMed ID: 32733164
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD.
Chen FJ; Lin GP; Huang XY; Liu YL; Zeng ZM; Guo YB
Int J Chron Obstruct Pulmon Dis; 2019; 14():2663-2671. PubMed ID: 31819399
[TBL] [Abstract][Full Text] [Related]
19. The Value of Inflammatory Biomarkers in Differentiating Asthma-COPD Overlap from COPD.
Li M; Yang T; He R; Li A; Dang W; Liu X; Chen M
Int J Chron Obstruct Pulmon Dis; 2020; 15():3025-3037. PubMed ID: 33244228
[TBL] [Abstract][Full Text] [Related]
20. Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.
Wang J; Lv H; Luo Z; Mou S; Liu J; Liu C; Deng S; Jiang Y; Lin J; Wu C; Liu X; He J; Jiang D
Respir Res; 2018 Mar; 19(1):47. PubMed ID: 29580282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
